A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease

NCT05413655 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: EX039
DRUG: Placebo

Sponsor

Excelsior

Collaborators

[object Object]